Life Sciences

Smith & Nephew receives subpoena from DOJ

Device Regulation Alert: Safety, Compliance and Reimbursement News, April 27, 2009

The Department of Justice subpoenaed documents relating to Smith & Nephew’s ultrasound stimulation product EXOGEN from 1995 and onward, the company announced.

EXOGEN is FDA approved for specific fresh fractures and long bone non-unions and was first marketed in 1998.

Smith & Nephew said it plans to comply fully with the request and believes its competitors have received similar subpoenas.

Most Popular